Natuzzi S.p.A.: Unaudited Consolidated Outcomes for the Fourth Quarter and Full Yr 2019

Natuzzi S.p.A.: Unaudited Consolidated Outcomes for the Fourth Quarter and Full Yr 2019

The Board of Administrators of Natuzzi S.p.A. (NYSE: NTZ1) ("Natuzzi” or the "Firm”) accepted as we speak its 2019 fourth quarter and

BrainStorm Cell Therapeutics to Announce Fourth Quarter and Full 12 months 2019 Monetary Outcomes and Present a Company Replace
South Africa Wholesale Gross sales Fall For Fourth Month
Wiz releases its fourth quarter of 2019 outcomes this Thursday (20/02)



The Board of Administrators of Natuzzi S.p.A. (NYSE: NTZ1) (“Natuzzi” or the “Firm”) accepted as we speak its 2019 fourth quarter and full 12 months unaudited consolidated monetary outcomes and the Firm’s draft stand-alone monetary statements. The stand-alone monetary statements of the Firm for the 12 months ended December 31, 2019 can be accepted by the Firm’s shareholders on a gathering to be held, on first name, on June 12, 2020, or, on second name, on June 14, 2020.


Replace on COVID-19 Affect on Group’s Operations


On March 11, 2020, the World Well being Group declared the latest outbreak of illness brought on by the novel coronavirus (COVID-19) a pandemic. Because of this, extreme lockdown measures have been launched in most international locations, resulting in a major discount within the Group’s and its clients’ actions worldwide.


Contemplating the worldwide evolution of the contagion and the uncertainties associated to its period and depth, it isn’t doable to find out the possible extent of the financial and social results of the pandemic on worldwide markets and, consequently, on the Group’s outcomes for the total present 12 months. The Firm expects that these results can be considerably unfavourable within the short-term.


Because of the disruptions and uncertainty generated by the COVID-19 pandemic, the Firm reacted instantly by organising a task-force with the aim of mitigating the…



https://markets.businessinsider.com

COMMENTS

WORDPRESS: 0